美他唑仑影响喹硫平代谢的药物相互作用研究
该研究基于治疗药物监测数据库,比较33例单用喹硫平患者与33例联用美他唑仑患者的喹硫平血浆浓度。结果显示联用组喹硫平浓度降低超过50%,剂量调整后浓度降低69%,且更多患者浓度低于治疗参考范围,提示美他唑仑可能通过诱导CYP3A4降低喹硫平暴露,增加治疗失败风险。
要点
- 联用美他唑仑可使喹硫平血浆浓度降低超过50%
- 剂量调整后喹硫平浓度降低69%,提示酶诱导作用
- 联用组78.8%患者喹硫平浓度低于治疗参考范围
核心结论
- 美他唑仑与喹硫平联用可显著降低喹硫平血浆浓度,可能通过诱导CYP3A4所致。
- 临床医生应警惕联用美他唑仑时喹硫平治疗失败的风险。
研究设计与样本
- 基于治疗药物监测数据库的血浆浓度分析,比较两组各33例患者。
- 单用喹硫平组(无CYP调节合用药物)与联用美他唑仑组进行比较。
主要发现
- 亚组分析未提示美他唑仑效应存在剂量依赖性,也未提示喹硫平剂型(速释 vs 缓释)的影响。
临床怎么用
- 在加用美他唑仑时,应监测喹硫平血浆浓度,评估治疗失败风险。
- 对于联用美他唑仑的患者,需关注喹硫平疗效不足的可能,必要时调整剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Metamizole is quite an old drug with analgesic, antipyretic and spasmolytic properties. Recent findings have shown that it may induce several cytochrome P450 (CYP) enzymes, especially CYP3A4 and CYP2B6. The clinical relevance of these properties is uncertain. We aimed to unravel potential pharmacokinetic interactions between metamizole and the CYP3A4 substrate quetiapine. METHODS: Plasma concentrations of quetiapine from a large therapeutic drug monitoring database were analysed. Two groups of 33 patients, either receiving quetiapine as a monotherapy (without CYP modulating comedications) or with concomitantly applied metamizole, were compared addressing a potential impact of metamizole on the metabolism of quetiapine being reflected in differences of plasma concentrations of quetiapine and dose-adjusted plasma concentrations. RESULTS: Patients comedicated with metamizole showed >50% lower plasma concentrations of quetiapine (median 45.2 ng/mL, Q1 = 15.5; Q3 = 90.5 vs. 92.0 ng/mL, Q1 = 52.3; Q3 = 203.8, P = .003). The dose-adjusted plasma concentrations were 69% lower in the comedication group (P = .001). Subgroup analyses did not suggest a dose dependency of the metamizole effect or an influence of quetiapine formulation (immediate vs. extended release). Finally, the comedication group exhibited a significantly higher proportion of patients whose quetiapine concentrations were below the therapeutic reference range (78.8% in the metamizole group vs. 54.4% in the control group, P = .037) indicating therapeutically insufficient drug concentrations. CONCLUSION: The combination of metamizole and quetiapine leads to significantly lower drug concentrations of quetiapine, probably via an induction of CYP3A4. Clinicians must consider the risk of adverse drug reactions, especially treatment failure under quetiapine when adding metamizole.
引用
- Watermeyer F, Gaebler AJ, Neuner I, et al. Discovering interactions in polypharmacy: Impact of metamizole on the metabolism of quetiapine. Br J Clin Pharmacol. 2024. PMID: 38970468. doi:10.1111/bcp.16168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。